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Erratum
Background: The complexity of the preanalytical 
(PA) phase has precluded standardisation of PA 
processes, despite its impact on sample quality, 
laboratory effi  ciency, or patient & healthcare work-
er safety. The BD Laboratory Consulting Services™ 
Preanalytical Review audits PA procedures and 
practices in hospitals in diff erent countries. Proc-
esses were assessed from storage of blood collec-
tion materials through specimen collection, trans-
portation, processing of the samples and the re-
sulting sample quality. By following the samples 
through the complete process, it was possible to 
link specifi c PA attributes to sample quality defi -
ciencies.
Materials and methods: A consistent method 
and data collection form were used for audits (N = 
48) of all blood collection systems. Data were col-
lected by observation of the PA phase. Sample 
quality was assessed for laboratory samples of the 
same type.
Results: The PA phase was observed for 3597 
blood collection tubes over 1350 collections. Sam-
ple quality was assessed for 8016 chemistry and 
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3532 coagulation tubes. For collections that result-
ed in hemolysed samples, 48% had prolonged use 
of tourniquet, 31% used catheters and for 38% the 
disinfectant was not allowed to dry. For serum 
samples with fi brin where the PA process had been 
observed, 26% had less than 30 minutes between 
collection and centrifugation and 81% had not 
been mixed. The following list gives the percent-
age of collections where a particular behaviour 
was observed, incorrect patient identifi cation pro-
cedure, 56%; tubes labelled prior to collection 61%; 
coagulation tubes fi lled to less than 90% of tube 
volume 7%; gloves not worn 37%; incorrect activa-
tion of needle safety device 19%.
Conclusions: The BD Preanalytical Review stand-
ardised audit methodology allows comparison of 
results between departments and institutions. The 
prospective nature of the reviews permits identifi -
cation of issues based on more data than from re-
jected samples alone and therefore aff ords a more 
complete understanding for those involved in the 
PA phase.
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